Cetirizine Hydrochloride Market Will Expand at 3.20% CAGR to Hit 1410 Million US$ by 2025: QY Research, Inc.
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
View full press release